The Annual General Meeting of Evotec AG will take place on Thursday, 14 June 2012, at 10:00 a.m. (CEST) at the offices of the firm at Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg.
Agenda.
- Presentation of the approved annual financial statements and the consolidated financial statements of Evotec AG as of 31 December 2011, as approved by the Supervisory Board, the management reports for Evotec AG and the Group for fiscal year 2011, the report of the Supervisory Board, and the comments by the Management Board regarding this information pursuant to §§ 289 (4), 315 (4) of the German Commercial Code (Handelsgesetzbuch, HGB).
- Resolution regarding formal approval of the actions of the members of the Management Board for fiscal year 2011.
- Resolution regarding the formal approval of the actions of the members of the Supervisory Board for fiscal year 2011.
- Resolution regarding the appointment of the auditor for the annual financial statements and the consolidated financial statements for fiscal year 2012.
- Resolution regarding the approval of the compensation system for members of the Management Board.
- Resolution regarding the creation of new authorised capital with the possibility of precluding subscription rights and amendment of § 5 (4) of the Articles of Association (Authorised Capital 2012)
- Resolution for the creation of contingent capital to grant subscription rights to members of the Management Board of Evotec AG, to members of the executive bodies of affiliated companies in Germany and abroad, and to selected executives of Evotec AG and affiliated companies in Germany and abroad, in the course of Share Performance Plan 2012 (SPP 2012), based on a resolution and an amendment to the Articles of Association
- Resolution for the amendment of dividend rights of new shares, issued in the future to serve stock option programmes from the contingent capital according to § 5, Pars. 5 to 8, 10, and 11, and the amendment of the Articles of Association
- Resolution regarding the amendment to the Exercise Periods for the company’s 2011 stock option programme
- Resolution authorizing the issuance of convertible bonds and/or warrant-linked bonds, participation rights and/or income bonds (or combinations of those instruments), creation of new contingent capital, and amendments to the Articles of Association
Agenda of the AGM (205 kB)
Direction (165,41 kB)
Counter Motions: No counter motions have been received
| Contact your HV-Team |
|
Evotec AG
Dr Werner Lanthaler
CEO
Gabriele Hansen Investor Relations & Corporate Communications
Manfred Eigen Campus
Essener Bogen 7 22419 Hamburg
T: +49.(0)40.5 60 81-255 F: +49.(0)40.5 60 81-333 hauptversammlung@evotec.com
|
| |
|
If you have any queries in conjunction with the issue of a proxy, contact our hotline on telephone No. +49.(0)89.889 690 620 from monday to friday 9.00 am to 5.00 pm (CEST)
|
| Your ADR contact |
|
JPMorgan Chase & Co.
P.O. Box 64504
St. Paul, MN 55164-0504
USA
T: 800.990 1135 (innerhalb der USA)
T: +1.651.453 2128 (von außerhalb der USA)
jpmorgan.adr@wellsfargo.com
|